Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Remdesivir for the treatment of COVID-19
- Ansems, Kelly
- Grundeis, Felicitas
- Dahms, Karolina
- Mikolajewska, Agata
- Thieme, Volker
- Piechotta, Vanessa
- Metzendorf, Maria-Inti
- Stegemann, Miriam
- Benstöm, Carina
- Fichtner, Falk
Publication date
July 2021
DOIAbstract
Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Remdesivir for the treatment of COVID-19.This review is part of the CEOsys project funded by the Network of University Medicine (Nationales Forschungsnetzwerk der Universitätsmedizin (NUM)) by the Federal Ministry of Education and Research of Germany (Bundesministerium für Bildung und Forschung (BMBF)), grant number 01KX2021
Add to ORKG